ICOLA 2023 STARTS IN 28DAYS20HOURS6MINUTES12SECONDS
2024 ICoLA 2026
일시
2026. 09. 10 (목) ~ 12 (토)
장소
Conrad Seoul, Republic of Korea
Program
ICoLA Program Call for Abstracts Registration Sponsorship General Information
Program at a Glance
Program at a Glance Program Details Speakers Key Lectures Main Symposia Joint Symposia Satellite Symposia Oral Presentations
ICoLA 2026 Programs Download
  • (K)Korean Session
  • (K+E)Korean & English Session
    (The language of each lecture may differ within the same session.)
Day 1 (Thursday, 10 September, 2026)
Day 2 (Friday, 11 September, 2026)
  Room 1 Room 2 Room 3 Room 4 Room 5
07:30-08:30 Breakfast Symposium 1 (K+E)

* Meal Service 07:30-08:00

** First Come, First Served

Breakfast Symposium 2

* Meal Service 07:30-08:00

** First Come, First Served

Breakfast Symposium 3

* Meal Service 07:30-08:00

** First Come, First Served

Breakfast Symposium 4

* Meal Service 07:30-08:00

** First Come, First Served

 
08:30-10:00 Oral Presentation 2 Symposium 10

New Frontiers in Lipid Lowering: Beyond Statins (New Drugs 1)

Symposium 11

Lipid-lowering Therapy in Complex Clinical Settings: HIV, Cancer, and Chronic Kidney Disease

Symposium 12

Bridging Cellular Physiology and Atherogenic Lipids

10:00-10:10 Break
10:10-10:20 Opening Address  
10:20-11:00 Plenary Lecture 1

The next frontier in cardiovascular prevention

11:00-11:40 Special Lecture (K)

Medicine in art (그림 속의 의학)

11:45-12:45 Luncheon Symposium 1 (K) Luncheon Symposium 2 Luncheon Symposium 3 Luncheon Symposium 4 (K) Luncheon Symposium 5
12:45-13:45 Poster Presentation Session 1 (Studio 5, 6, 7, 6F)  
Symposium 13

Sex-specific Lipid Biology and Cardiometabolic Risk across the Lifespan

    Symposium 14

2026 KSoLA Awards for Scientific Excellence & Digital Health Media and Ethics

13:45-15:15 Symposium 15

Official Launch of the 2026 KSoLA Guidelines for the Management of Dyslipidemia

VAS-KSoLA Joint Symposium

Residual Cardiovascular Risk Beyond LDL-C: The Emerging Role of Lipoprotein(a) in Asia

Symposium 16

Evolution of High-risk Coronary Plaques: From Hemodynamics to Multimodality Assessment

Symposium 17

Metabolic Dysfunction, Fatty Liver, and Atherosclerosis

15:20-16:00 Plenary Lecture 2

Closing the gap between guidelines and reality in dyslipidemia management

 
16:00-16:10 Break
16:10-17:40 Symposium 18

Intensive LDL-C Lowering in Primary Prevention

Symposium 19

Next-generation Lipid-lowering Therapies: CETP, APOC3, and ANGPTL3 Inhibition (New Drugs 2)

Symposium 20

Residual Cardiovascular Risk: Beyond LDL to Inflammation and Novel Targets

Symposium 21

Atherogenic Obesity: Beyond BMI to Lipid Dysfunction

Day 3 (Saturday 12, September, 2026)
  Room 1 Room 2 Room 3 Room 4
07:50-08:50 Breakfast Symposium 5

* Meal Service 07:50-08:20

** First Come, First Served

Breakfast Symposium 6

* Meal Service 07:50-08:20

** First Come, First Served

Breakfast Symposium 7

* Meal Service 07:50-08:20

** First Come, First Served

Breakfast Symposium 8

* Meal Service 07:50-08:20

** First Come, First Served

08:50-10:20 Oral Presentation 3 TSLA-KSoLA Joint Symposium

Contemporary Management of Residual Cardiovascular Risk in Asia

Symposium 22

Lp(a) beyond the Known: From Metabolic Pathways to Clinical Translation

MSA-KSoLA Joint Symposium

From Diversity to Action: Ethnicity, Genetics, and Closing the Treatment Gap in Asian Dyslipidemia

10:20-10:40 Coffee Break
10:40-11:20 Plenary Lecture 3

Beyond LDL-C lowering: strategies for maximizing residual ASCVD risk reduction

 
11:20-12:00 Plenary Lecture 4

Perspective on residual risk, inflammation, and atherosclerosis: from epidemiology to precision prevention

12:00-13:00 Luncheon Symposium 6 (K) Luncheon Symposium 7 Luncheon Symposium 8
13:00-14:00 Poster Presentation Session 2 (Studio 5, 6, 7, 6F)
Symposium 23

Hypertension, Lipids, and Vascular Aging: Integrated Cardiovascular Risk Management

Symposium 24

Beyond Stening: Contemporary Management of Residual Coronary Risk

Symposium 25

Integrated Cardiometabolic Risk Management in Diabetes

 
14:00-14:10 Break
14:10-15:40 Symposium 26

Integrated Cardiovascular-kidney-metabolic Care: A Multidisciplinary Approach to CKM Syndrome

Symposium 27

AI-driven Innovations in Atherosclerosis

Symposium 28

Primary Prevention in Cardiovascular Disease: Beyond Traditional Risk Factors

Symposium 29

Lipid Metabolism across Endocrine Disorders: From Mechanism to Clinical Practice

15:40-17:10 Symposium 30

Neural and Genetic Control of Eating Behavior and Cardiometabolic Health

EAS-KSoLA Joint Symposium

Bridging Europe and Korea in Dyslipidemia Management: Guidelines, Gaps, and Future Directions

Symposium 31

From Cells to Systems: Integrated Control of Cardiometabolic Health

Symposium 32

Environmental Cardiovascular Risk

17:10- Closing Ceremony (Room 1,2,3, 3F)  

TOP

현재 브라우저에서는 지원하지 않는 사이트입니다. 아래의 다른 브라우저를 다운받아 사용해주세요.